Prognostic Significance of HER2 Gene Amplification According to Stage of Breast Cancer
Author:
Affiliation:
1. Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea.
2. Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Publisher
Korean Academy of Medical Sciences
Subject
General Medicine
Link
https://synapse.koreamed.org/pdf/10.3346/jkms.2008.23.3.414
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Hurdle of Precision Medicine in Cancer Immunotherapy: Personalization Now or Then?;Handbook of Cancer and Immunology;2023
2. Association radiothérapie et trastuzumab : rationnel et implications cliniques;Bulletin du Cancer;2021-05
3. Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2/CEP17 ratio in HER2 overexpressing breast cancer: analysis of the National Cancer Database (NCDB);Breast Cancer Research and Treatment;2020-04-10
4. Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma;Modern Pathology;2020-01-23
5. Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies;Breast Cancer Research and Treatment;2019-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3